Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2026-02-28 @ 11:42 PM
Study NCT ID:
NCT03194334
Status:
COMPLETED
Last Update Posted:
2019-02-28
First Post:
2017-06-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Creatine, Carnitine and Carnosine in Vegetarians
Sponsor:
Organization:
Raw JSON
{'hasResults': True, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'interventionBrowseModule': {'meshes': [{'id': 'D014676', 'term': 'Diet, Vegetarian'}, {'id': 'D003401', 'term': 'Creatine'}, {'id': 'D015091', 'term': 'beta-Alanine'}], 'ancestors': [{'id': 'D000095500', 'term': 'Diet, Plant-Based'}, {'id': 'D004035', 'term': 'Diet Therapy'}, {'id': 'D044623', 'term': 'Nutrition Therapy'}, {'id': 'D013812', 'term': 'Therapeutics'}, {'id': 'D004032', 'term': 'Diet'}, {'id': 'D009747', 'term': 'Nutritional Physiological Phenomena'}, {'id': 'D000066888', 'term': 'Diet, Food, and Nutrition'}, {'id': 'D010829', 'term': 'Physiological Phenomena'}, {'id': 'D006146', 'term': 'Guanidines'}, {'id': 'D000578', 'term': 'Amidines'}, {'id': 'D009930', 'term': 'Organic Chemicals'}, {'id': 'D000596', 'term': 'Amino Acids'}, {'id': 'D000602', 'term': 'Amino Acids, Peptides, and Proteins'}, {'id': 'D000409', 'term': 'Alanine'}]}}, 'resultsSection': {'moreInfoModule': {'pointOfContact': {'email': 'wim.derave@ugent.be', 'phone': '+32/9/2646326', 'title': 'Prof. Wim Derave', 'organization': 'University Ghent'}, 'certainAgreement': {'piSponsorEmployee': True}, 'limitationsAndCaveats': {'description': 'A far too low number of subjects consented to have muscle biopsies taken at 6M. Therefore, muscle analyses were restricted to the 0 and 3M time points.'}}, 'adverseEventsModule': {'eventGroups': [{'id': 'EG000', 'title': 'Control', 'description': 'continued their omnivorous diet throughout the entire study', 'otherNumAtRisk': 10, 'deathsNumAtRisk': 10, 'otherNumAffected': 0, 'seriousNumAtRisk': 10, 'deathsNumAffected': 0, 'seriousNumAffected': 0}, {'id': 'EG001', 'title': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine\n\nVegetarian diet\n\nPlacebo: pills', 'otherNumAtRisk': 15, 'deathsNumAtRisk': 15, 'otherNumAffected': 0, 'seriousNumAtRisk': 15, 'deathsNumAffected': 0, 'seriousNumAffected': 0}, {'id': 'EG002', 'title': 'Veg+Suppl', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day\n\nVegetarian diet\n\ncreatine and beta-alanine', 'otherNumAtRisk': 14, 'deathsNumAtRisk': 14, 'otherNumAffected': 0, 'seriousNumAtRisk': 14, 'deathsNumAffected': 0, 'seriousNumAffected': 0}], 'frequencyThreshold': '0'}, 'outcomeMeasuresModule': {'outcomeMeasures': [{'type': 'PRIMARY', 'title': 'Fasted Plasma Beta-alanine Concentration', 'denoms': [{'units': 'Participants', 'counts': [{'value': '10', 'groupId': 'OG000'}, {'value': '15', 'groupId': 'OG001'}, {'value': '14', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Control', 'description': 'continued their omnivorous diet throughout the entire study'}, {'id': 'OG001', 'title': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine\n\nVegetarian diet\n\nPlacebo: pills'}, {'id': 'OG002', 'title': 'Veg+Suppl', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day\n\nVegetarian diet\n\ncreatine and beta-alanine'}], 'classes': [{'title': 'Basline', 'categories': [{'measurements': [{'value': '3.37', 'spread': '1.96', 'groupId': 'OG000'}, {'value': '5.19', 'spread': '2.26', 'groupId': 'OG001'}, {'value': '4.56', 'spread': '2.74', 'groupId': 'OG002'}]}]}, {'title': '3 months', 'categories': [{'measurements': [{'value': '3.76', 'spread': '2.58', 'groupId': 'OG000'}, {'value': '5.11', 'spread': '1.99', 'groupId': 'OG001'}, {'value': '5.8', 'spread': '3.24', 'groupId': 'OG002'}]}]}, {'title': '6 months', 'categories': [{'measurements': [{'value': '3.9', 'spread': '2.88', 'groupId': 'OG000'}, {'value': '5.59', 'spread': '2.63', 'groupId': 'OG001'}, {'value': '5.42', 'spread': '3.99', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': '6 months', 'description': 'Fasted venous plasma beta-alanine concentration (precursor for carnosine) at 0, 3 and 6 months of the intervention', 'unitOfMeasure': 'µM', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Gastrocnemius Carnosine Concentration', 'denoms': [{'units': 'Participants', 'counts': [{'value': '10', 'groupId': 'OG000'}, {'value': '15', 'groupId': 'OG001'}, {'value': '14', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Control', 'description': 'continued their omnivorous diet throughout the entire study'}, {'id': 'OG001', 'title': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine\n\nVegetarian diet\n\nPlacebo: pills'}, {'id': 'OG002', 'title': 'Veg+ Creatine and Beta-alanine', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day\n\nVegetarian diet\n\ncreatine: 1g creatine/day\n\nBeta-alanine: 0.8g beta-alanine per day'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '5.18', 'spread': '1.21', 'groupId': 'OG000'}, {'value': '5.16', 'spread': '1.46', 'groupId': 'OG001'}, {'value': '5.1', 'spread': '1.61', 'groupId': 'OG002'}]}]}, {'title': '3 months', 'categories': [{'measurements': [{'value': '5.58', 'spread': '0.97', 'groupId': 'OG000'}, {'value': '5.55', 'spread': '1.4', 'groupId': 'OG001'}, {'value': '6.55', 'spread': '1.53', 'groupId': 'OG002'}]}]}, {'title': '6 months', 'categories': [{'measurements': [{'value': '5.68', 'spread': '1.07', 'groupId': 'OG000'}, {'value': '5.81', 'spread': '1.82', 'groupId': 'OG001'}, {'value': '7.19', 'spread': '2.11', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': '6 months', 'description': 'Gastrocnemius carnosine concentration at 0, 3 and 6 months of the intervention', 'unitOfMeasure': 'mM', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Soleus Carnosine Concentration', 'denoms': [{'units': 'Participants', 'counts': [{'value': '10', 'groupId': 'OG000'}, {'value': '15', 'groupId': 'OG001'}, {'value': '14', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Control', 'description': 'continued their omnivorous diet throughout the entire study'}, {'id': 'OG001', 'title': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine\n\nVegetarian diet\n\nPlacebo: pills'}, {'id': 'OG002', 'title': 'Veg+Suppl', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day\n\nVegetarian diet\n\ncreatine and beta-alanine'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '3.91', 'spread': '0.43', 'groupId': 'OG000'}, {'value': '3.53', 'spread': '0.94', 'groupId': 'OG001'}, {'value': '3.7', 'spread': '1.08', 'groupId': 'OG002'}]}]}, {'title': '3 months', 'categories': [{'measurements': [{'value': '3.84', 'spread': '0.74', 'groupId': 'OG000'}, {'value': '3.36', 'spread': '0.97', 'groupId': 'OG001'}, {'value': '4.72', 'spread': '1.11', 'groupId': 'OG002'}]}]}, {'title': '6 months', 'categories': [{'measurements': [{'value': '4.0', 'spread': '0.72', 'groupId': 'OG000'}, {'value': '3.65', 'spread': '1.38', 'groupId': 'OG001'}, {'value': '4.67', 'spread': '1.38', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': '6 months', 'description': 'Soleus carnosine concentration at 0, 3 and 6 months of the intervention', 'unitOfMeasure': 'mM', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Plasma Creatine Concentration', 'denoms': [{'units': 'Participants', 'counts': [{'value': '10', 'groupId': 'OG000'}, {'value': '15', 'groupId': 'OG001'}, {'value': '14', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Control', 'description': 'continued their omnivorous diet throughout the entire study'}, {'id': 'OG001', 'title': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine\n\nVegetarian diet\n\nPlacebo: pills'}, {'id': 'OG002', 'title': 'Veg+Suppl', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day\n\nVegetarian diet\n\ncreatine and beta-alanine'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '35.7', 'spread': '19.8', 'groupId': 'OG000'}, {'value': '29.7', 'spread': '15.3', 'groupId': 'OG001'}, {'value': '27.3', 'spread': '9.6', 'groupId': 'OG002'}]}]}, {'title': '3 months', 'categories': [{'measurements': [{'value': '28.1', 'spread': '11.9', 'groupId': 'OG000'}, {'value': '15.8', 'spread': '10.0', 'groupId': 'OG001'}, {'value': '56.9', 'spread': '36.3', 'groupId': 'OG002'}]}]}, {'title': '6 months', 'categories': [{'measurements': [{'value': '40.6', 'spread': '21.6', 'groupId': 'OG000'}, {'value': '16.1', 'spread': '7.9', 'groupId': 'OG001'}, {'value': '80.7', 'spread': '65.7', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': '6 months', 'description': 'Plasma creatine concentration at 0, 3 and 6 months of the intervention', 'unitOfMeasure': 'µmol/L', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Plasma Creatinine Concentration', 'denoms': [{'units': 'Participants', 'counts': [{'value': '10', 'groupId': 'OG000'}, {'value': '15', 'groupId': 'OG001'}, {'value': '14', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Control', 'description': 'continued their omnivorous diet throughout the entire study'}, {'id': 'OG001', 'title': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine\n\nVegetarian diet\n\nPlacebo: pills'}, {'id': 'OG002', 'title': 'Veg+Suppl', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day\n\nVegetarian diet\n\ncreatine and beta-alanine'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '97.33', 'spread': '7.8', 'groupId': 'OG000'}, {'value': '79.49', 'spread': '29.09', 'groupId': 'OG001'}, {'value': '79.9', 'spread': '15.83', 'groupId': 'OG002'}]}]}, {'title': '3 months', 'categories': [{'measurements': [{'value': '96.62', 'spread': '15.1', 'groupId': 'OG000'}, {'value': '85.68', 'spread': '30.94', 'groupId': 'OG001'}, {'value': '78.47', 'spread': '17.8', 'groupId': 'OG002'}]}]}, {'title': '6 months', 'categories': [{'measurements': [{'value': '96.18', 'spread': '17.5', 'groupId': 'OG000'}, {'value': '75.41', 'spread': '26.35', 'groupId': 'OG001'}, {'value': '88.13', 'spread': '17.09', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': '6 months', 'description': 'Plasma creatinine at 0, 3 and 6 months of the intervention', 'unitOfMeasure': 'µmol/L', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Plasma Guanidinoacetate Concentration', 'denoms': [{'units': 'Participants', 'counts': [{'value': '10', 'groupId': 'OG000'}, {'value': '15', 'groupId': 'OG001'}, {'value': '14', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Control', 'description': 'continued their omnivorous diet throughout the entire study'}, {'id': 'OG001', 'title': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine\n\nVegetarian diet\n\nPlacebo: pills'}, {'id': 'OG002', 'title': 'Veg+Suppl', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day\n\nVegetarian diet\n\ncreatine and beta-alanine'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '2.23', 'spread': '0.49', 'groupId': 'OG000'}, {'value': '2.06', 'spread': '0.59', 'groupId': 'OG001'}, {'value': '1.95', 'spread': '0.52', 'groupId': 'OG002'}]}]}, {'title': '3 months', 'categories': [{'measurements': [{'value': '2.2', 'spread': '0.55', 'groupId': 'OG000'}, {'value': '2.05', 'spread': '0.63', 'groupId': 'OG001'}, {'value': '1.87', 'spread': '0.72', 'groupId': 'OG002'}]}]}, {'title': '6 months', 'categories': [{'measurements': [{'value': '2.42', 'spread': '0.92', 'groupId': 'OG000'}, {'value': '2.0', 'spread': '0.63', 'groupId': 'OG001'}, {'value': '1.75', 'spread': '0.67', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': '6 months', 'description': 'Plasma guanidinoacetate at 0, 3 and 6 months of the intervention', 'unitOfMeasure': 'µmol/L', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Urinary Creatinine Concentration', 'denoms': [{'units': 'Participants', 'counts': [{'value': '10', 'groupId': 'OG000'}, {'value': '15', 'groupId': 'OG001'}, {'value': '14', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Control', 'description': 'continued their omnivorous diet throughout the entire study'}, {'id': 'OG001', 'title': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine\n\nVegetarian diet\n\nPlacebo: pills'}, {'id': 'OG002', 'title': 'Veg+Suppl', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day\n\nVegetarian diet\n\ncreatine and beta-alanine'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '1298.62', 'spread': '269.46', 'groupId': 'OG000'}, {'value': '1235.99', 'spread': '233.05', 'groupId': 'OG001'}, {'value': '1254.65', 'spread': '243.38', 'groupId': 'OG002'}]}]}, {'title': '3 months', 'categories': [{'measurements': [{'value': '1258.78', 'spread': '680.31', 'groupId': 'OG000'}, {'value': '1034.3', 'spread': '220.92', 'groupId': 'OG001'}, {'value': '1279.41', 'spread': '215.92', 'groupId': 'OG002'}]}]}, {'title': '6 months', 'categories': [{'measurements': [{'value': '990.25', 'spread': '298.77', 'groupId': 'OG000'}, {'value': '941.71', 'spread': '114.46', 'groupId': 'OG001'}, {'value': '1090.67', 'spread': '235.57', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': '6 months', 'description': 'Urinary creatinine at 0, 3 and 6 months of the intervention', 'unitOfMeasure': 'mg/24h', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Muscle Creatine Concentration', 'denoms': [{'units': 'Participants', 'counts': [{'value': '10', 'groupId': 'OG000'}, {'value': '15', 'groupId': 'OG001'}, {'value': '14', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Control', 'description': 'continued their omnivorous diet throughout the entire study'}, {'id': 'OG001', 'title': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine\n\nVegetarian diet\n\nPlacebo: pills'}, {'id': 'OG002', 'title': 'Veg+Suppl', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day\n\nVegetarian diet\n\ncreatine and beta-alanine'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '133.2', 'spread': '11.6', 'groupId': 'OG000'}, {'value': '153.5', 'spread': '24.0', 'groupId': 'OG001'}, {'value': '128.2', 'spread': '14.9', 'groupId': 'OG002'}]}]}, {'title': '3 months', 'categories': [{'measurements': [{'value': '142.2', 'spread': '12.7', 'groupId': 'OG000'}, {'value': '128.8', 'spread': '11.6', 'groupId': 'OG001'}, {'value': '140.7', 'spread': '17.4', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': '3 months', 'description': 'Muscle total creatine concentration in vastus lateralis muscle at 0 and 3 months of the intervention', 'unitOfMeasure': 'mmol/kg', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Plasma Carnitine Concentration', 'denoms': [{'units': 'Participants', 'counts': [{'value': '10', 'groupId': 'OG000'}, {'value': '15', 'groupId': 'OG001'}, {'value': '14', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Control', 'description': 'continued their omnivorous diet throughout the entire study'}, {'id': 'OG001', 'title': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine\n\nVegetarian diet\n\nPlacebo: pills'}, {'id': 'OG002', 'title': 'Veg+Suppl', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day\n\nVegetarian diet\n\ncreatine and beta-alanine'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '30.81', 'spread': '6.6', 'groupId': 'OG000'}, {'value': '29.82', 'spread': '4.45', 'groupId': 'OG001'}, {'value': '28.39', 'spread': '6.38', 'groupId': 'OG002'}]}]}, {'title': '3 months', 'categories': [{'measurements': [{'value': '28.7', 'spread': '6.11', 'groupId': 'OG000'}, {'value': '26.45', 'spread': '6.21', 'groupId': 'OG001'}, {'value': '25.71', 'spread': '6.22', 'groupId': 'OG002'}]}]}, {'title': '6 months', 'categories': [{'measurements': [{'value': '31.71', 'spread': '6.75', 'groupId': 'OG000'}, {'value': '28.23', 'spread': '4.88', 'groupId': 'OG001'}, {'value': '27.31', 'spread': '7.8', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': '6 months', 'description': 'plasma free carnitine concentration at 0, 3 and 6 months of the intervention', 'unitOfMeasure': 'µmol/L', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Plasma Acetylcarnitine Concentration', 'denoms': [{'units': 'Participants', 'counts': [{'value': '10', 'groupId': 'OG000'}, {'value': '15', 'groupId': 'OG001'}, {'value': '14', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Control', 'description': 'continued their omnivorous diet throughout the entire study'}, {'id': 'OG001', 'title': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine\n\nVegetarian diet\n\nPlacebo: pills'}, {'id': 'OG002', 'title': 'Veg+Suppl', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day\n\nVegetarian diet\n\ncreatine and beta-alanine'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '8.49', 'spread': '2.24', 'groupId': 'OG000'}, {'value': '7.71', 'spread': '1.95', 'groupId': 'OG001'}, {'value': '8.09', 'spread': '1.98', 'groupId': 'OG002'}]}]}, {'title': '3 months', 'categories': [{'measurements': [{'value': '6.82', 'spread': '1.31', 'groupId': 'OG000'}, {'value': '6.93', 'spread': '1.78', 'groupId': 'OG001'}, {'value': '6.77', 'spread': '1.33', 'groupId': 'OG002'}]}]}, {'title': '6 months', 'categories': [{'measurements': [{'value': '7.15', 'spread': '1.41', 'groupId': 'OG000'}, {'value': '7.54', 'spread': '1.67', 'groupId': 'OG001'}, {'value': '7.15', 'spread': '3.16', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': '6 months', 'description': 'plasma acetylcarnitine concentration at 0, 3 and 6 months of the intervention', 'unitOfMeasure': 'µmol/L', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Plasma Total Carnitine Concentration', 'denoms': [{'units': 'Participants', 'counts': [{'value': '10', 'groupId': 'OG000'}, {'value': '15', 'groupId': 'OG001'}, {'value': '14', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Control', 'description': 'continued their omnivorous diet throughout the entire study'}, {'id': 'OG001', 'title': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine\n\nVegetarian diet\n\nPlacebo: pills'}, {'id': 'OG002', 'title': 'Veg+Suppl', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day\n\nVegetarian diet\n\ncreatine and beta-alanine'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '41.58', 'spread': '6.97', 'groupId': 'OG000'}, {'value': '40.85', 'spread': '7.42', 'groupId': 'OG001'}, {'value': '40.24', 'spread': '5.75', 'groupId': 'OG002'}]}]}, {'title': '3 months', 'categories': [{'measurements': [{'value': '37.96', 'spread': '6.44', 'groupId': 'OG000'}, {'value': '36.16', 'spread': '7.83', 'groupId': 'OG001'}, {'value': '35.9', 'spread': '5.48', 'groupId': 'OG002'}]}]}, {'title': '6 months', 'categories': [{'measurements': [{'value': '41.25', 'spread': '8.02', 'groupId': 'OG000'}, {'value': '38.58', 'spread': '6.45', 'groupId': 'OG001'}, {'value': '37.87', 'spread': '9.51', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': '6 months', 'description': 'plasma total carnitine concentration (free + acetyl) at 0, 3 and 6 months of the intervention', 'unitOfMeasure': 'µmol/L', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Muscle Carnitine Concentration', 'denoms': [{'units': 'Participants', 'counts': [{'value': '10', 'groupId': 'OG000'}, {'value': '15', 'groupId': 'OG001'}, {'value': '14', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Control', 'description': 'continued their omnivorous diet throughout the entire study'}, {'id': 'OG001', 'title': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine\n\nVegetarian diet\n\nPlacebo: pills'}, {'id': 'OG002', 'title': 'Veg+Suppl', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day\n\nVegetarian diet\n\ncreatine and beta-alanine'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '13.1', 'spread': '4.0', 'groupId': 'OG000'}, {'value': '12.1', 'spread': '4.1', 'groupId': 'OG001'}, {'value': '10.7', 'spread': '2.8', 'groupId': 'OG002'}]}]}, {'title': '3 months', 'categories': [{'measurements': [{'value': '11.5', 'spread': '2.9', 'groupId': 'OG000'}, {'value': '11.5', 'spread': '4.9', 'groupId': 'OG001'}, {'value': '9.7', 'spread': '3.2', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': '3 months', 'description': 'muscle free carnitine concentration in vastus lateralis muscle at 0 and 3 months of the intervention', 'unitOfMeasure': 'mmol/kg dry weight', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Muscle Acetylcarnitine Concentration', 'denoms': [{'units': 'Participants', 'counts': [{'value': '10', 'groupId': 'OG000'}, {'value': '15', 'groupId': 'OG001'}, {'value': '14', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Control', 'description': 'continued their omnivorous diet throughout the entire study'}, {'id': 'OG001', 'title': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine\n\nVegetarian diet\n\nPlacebo: pills'}, {'id': 'OG002', 'title': 'Veg+Suppl', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day\n\nVegetarian diet\n\ncreatine and beta-alanine'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '3.3', 'spread': '3.2', 'groupId': 'OG000'}, {'value': '4.2', 'spread': '2.4', 'groupId': 'OG001'}, {'value': '3.3', 'spread': '2.9', 'groupId': 'OG002'}]}]}, {'title': '3 months', 'categories': [{'measurements': [{'value': '3.6', 'spread': '1.9', 'groupId': 'OG000'}, {'value': '3.5', 'spread': '4.1', 'groupId': 'OG001'}, {'value': '3.2', 'spread': '2.5', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': '3 months', 'description': 'muscle acetylcarnitine concentration in vastus lateralis muscle at 0 and 3 months of the intervention', 'unitOfMeasure': 'mmol/kg dry weight', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Muscle Total Carnitine Concentration', 'denoms': [{'units': 'Participants', 'counts': [{'value': '10', 'groupId': 'OG000'}, {'value': '15', 'groupId': 'OG001'}, {'value': '14', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Control', 'description': 'continued their omnivorous diet throughout the entire study'}, {'id': 'OG001', 'title': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine\n\nVegetarian diet\n\nPlacebo: pills'}, {'id': 'OG002', 'title': 'Veg+Suppl', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day\n\nVegetarian diet\n\ncreatine and beta-alanine'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '16.5', 'spread': '2.4', 'groupId': 'OG000'}, {'value': '16.3', 'spread': '3.5', 'groupId': 'OG001'}, {'value': '13.9', 'spread': '2.3', 'groupId': 'OG002'}]}]}, {'title': '3 months', 'categories': [{'measurements': [{'value': '15.5', 'spread': '3.2', 'groupId': 'OG000'}, {'value': '13.6', 'spread': '2.3', 'groupId': 'OG001'}, {'value': '12.7', 'spread': '2.2', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': '3 months', 'description': 'muscle total carnitine concentration (free + acetylcarnitine) in vastus lateralis muscle at 0 and 3 months of the intervention', 'unitOfMeasure': 'mmol/kg dry weight', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'SECONDARY', 'title': 'Vitamin D Status', 'denoms': [{'units': 'Participants', 'counts': [{'value': '10', 'groupId': 'OG000'}, {'value': '15', 'groupId': 'OG001'}, {'value': '14', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Control', 'description': 'continued their omnivorous diet throughout the entire study'}, {'id': 'OG001', 'title': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine\n\nVegetarian diet\n\nPlacebo: pills'}, {'id': 'OG002', 'title': 'Veg+Suppl', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day\n\nVegetarian diet\n\ncreatine and beta-alanine'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '32.7', 'spread': '13.6', 'groupId': 'OG000'}, {'value': '29.1', 'spread': '10.3', 'groupId': 'OG001'}, {'value': '29.8', 'spread': '8.9', 'groupId': 'OG002'}]}]}, {'title': '3 months', 'categories': [{'measurements': [{'value': '24.9', 'spread': '10.0', 'groupId': 'OG000'}, {'value': '22.7', 'spread': '9.0', 'groupId': 'OG001'}, {'value': '24.6', 'spread': '7.8', 'groupId': 'OG002'}]}]}, {'title': '6 months', 'categories': [{'measurements': [{'value': '34.6', 'spread': '14.1', 'groupId': 'OG000'}, {'value': '30.1', 'spread': '10.8', 'groupId': 'OG001'}, {'value': '31.1', 'spread': '9.1', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': '6 months', 'description': 'Serum 25-Hydroxyvitamin D concentration at 0, 3 and 6 months of the intervention', 'unitOfMeasure': 'ng/ml', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'SECONDARY', 'title': 'Urinary Biomarker for Meat Intake: Pi-methyl-histidine', 'denoms': [{'units': 'Participants', 'counts': [{'value': '10', 'groupId': 'OG000'}, {'value': '15', 'groupId': 'OG001'}, {'value': '14', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Control', 'description': 'continued their omnivorous diet throughout the entire study'}, {'id': 'OG001', 'title': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine\n\nVegetarian diet\n\nPlacebo: pills'}, {'id': 'OG002', 'title': 'Veg+Suppl', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day\n\nVegetarian diet\n\ncreatine and beta-alanine'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '161.9', 'spread': '111.2', 'groupId': 'OG000'}, {'value': '167.4', 'spread': '145.3', 'groupId': 'OG001'}, {'value': '212.9', 'spread': '201.0', 'groupId': 'OG002'}]}]}, {'title': '3 months', 'categories': [{'measurements': [{'value': '117.8', 'spread': '124.8', 'groupId': 'OG000'}, {'value': '26.4', 'spread': '10.7', 'groupId': 'OG001'}, {'value': '28.7', 'spread': '9.1', 'groupId': 'OG002'}]}]}, {'title': '6 months', 'categories': [{'measurements': [{'value': '122.5', 'spread': '168.8', 'groupId': 'OG000'}, {'value': '15.1', 'spread': '4.7', 'groupId': 'OG001'}, {'value': '18.0', 'spread': '6.7', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': '6 months', 'description': 'urinary pi-methyl-histidine concentration at 0, 3 and 6 months of the intervention', 'unitOfMeasure': 'mg/24h', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'SECONDARY', 'title': 'Urinary Biomarker for Meat Intake: Tau-methyl-histidine', 'denoms': [{'units': 'Participants', 'counts': [{'value': '10', 'groupId': 'OG000'}, {'value': '15', 'groupId': 'OG001'}, {'value': '14', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Control', 'description': 'continued their omnivorous diet throughout the entire study'}, {'id': 'OG001', 'title': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine\n\nVegetarian diet\n\nPlacebo: pills'}, {'id': 'OG002', 'title': 'Veg+Suppl', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day\n\nVegetarian diet\n\ncreatine and beta-alanine'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '55.2', 'spread': '25.3', 'groupId': 'OG000'}, {'value': '63.1', 'spread': '20.0', 'groupId': 'OG001'}, {'value': '63.0', 'spread': '22.3', 'groupId': 'OG002'}]}]}, {'title': '3 months', 'categories': [{'measurements': [{'value': '74.6', 'spread': '61.6', 'groupId': 'OG000'}, {'value': '43.1', 'spread': '15.3', 'groupId': 'OG001'}, {'value': '46.1', 'spread': '16.0', 'groupId': 'OG002'}]}]}, {'title': '6 months', 'categories': [{'measurements': [{'value': '42.6', 'spread': '21.5', 'groupId': 'OG000'}, {'value': '27.6', 'spread': '7.1', 'groupId': 'OG001'}, {'value': '26.5', 'spread': '8.5', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': '6 months', 'description': 'urinary tau-methyl-histidine concentration at 0, 3 and 6 months of the intervention', 'unitOfMeasure': 'mg/24h', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'SECONDARY', 'title': 'Urinary Biomarker for Meat Intake: Anserine', 'denoms': [{'units': 'Participants', 'counts': [{'value': '10', 'groupId': 'OG000'}, {'value': '15', 'groupId': 'OG001'}, {'value': '14', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Control', 'description': 'continued their omnivorous diet throughout the entire study'}, {'id': 'OG001', 'title': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine\n\nVegetarian diet\n\nPlacebo: pills'}, {'id': 'OG002', 'title': 'Veg+Suppl', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day\n\nVegetarian diet\n\ncreatine and beta-alanine'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '15.0', 'spread': '14.3', 'groupId': 'OG000'}, {'value': '9.2', 'spread': '7.9', 'groupId': 'OG001'}, {'value': '10.7', 'spread': '12.9', 'groupId': 'OG002'}]}]}, {'title': '3 months', 'categories': [{'measurements': [{'value': '9.5', 'spread': '7.4', 'groupId': 'OG000'}, {'value': '5.5', 'spread': '2.9', 'groupId': 'OG001'}, {'value': '4.4', 'spread': '2.2', 'groupId': 'OG002'}]}]}, {'title': '6 months', 'categories': [{'measurements': [{'value': '11.6', 'spread': '23.2', 'groupId': 'OG000'}, {'value': '4.0', 'spread': '1.9', 'groupId': 'OG001'}, {'value': '2.6', 'spread': '1.1', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': '6 months', 'description': 'urinary anserine concentration at 0, 3 and 6 months of the intervention', 'unitOfMeasure': 'mg/24h', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'SECONDARY', 'title': 'VO2max', 'denoms': [{'units': 'Participants', 'counts': [{'value': '10', 'groupId': 'OG000'}, {'value': '15', 'groupId': 'OG001'}, {'value': '14', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Control', 'description': 'continued their omnivorous diet throughout the entire study'}, {'id': 'OG001', 'title': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine\n\nVegetarian diet\n\nPlacebo: pills'}, {'id': 'OG002', 'title': 'Veg+Suppl', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day\n\nVegetarian diet\n\ncreatine and beta-alanine'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '40.4', 'spread': '6.4', 'groupId': 'OG000'}, {'value': '39.4', 'spread': '6.4', 'groupId': 'OG001'}, {'value': '36.6', 'spread': '6.3', 'groupId': 'OG002'}]}]}, {'title': '3 months', 'categories': [{'measurements': [{'value': '39.0', 'spread': '8.8', 'groupId': 'OG000'}, {'value': '37.8', 'spread': '8.0', 'groupId': 'OG001'}, {'value': '34.8', 'spread': '4.7', 'groupId': 'OG002'}]}]}, {'title': '6 months', 'categories': [{'measurements': [{'value': '39.4', 'spread': '6.9', 'groupId': 'OG000'}, {'value': '38.1', 'spread': '6.6', 'groupId': 'OG001'}, {'value': '34.5', 'spread': '4.9', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': '6 months', 'description': 'VO2max during incremental cycling test performed at 0, 3 and 6 months', 'unitOfMeasure': 'ml/min/kg', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'SECONDARY', 'title': 'Time to Exhaustion', 'denoms': [{'units': 'Participants', 'counts': [{'value': '10', 'groupId': 'OG000'}, {'value': '15', 'groupId': 'OG001'}, {'value': '14', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Control', 'description': 'continued their omnivorous diet throughout the entire study'}, {'id': 'OG001', 'title': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine\n\nVegetarian diet\n\nPlacebo: pills'}, {'id': 'OG002', 'title': 'Veg+Suppl', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day\n\nVegetarian diet\n\ncreatine and beta-alanine'}], 'classes': [{'title': 'Baseline', 'categories': [{'measurements': [{'value': '14.5', 'spread': '1.9', 'groupId': 'OG000'}, {'value': '15.1', 'spread': '2.7', 'groupId': 'OG001'}, {'value': '13.8', 'spread': '2.6', 'groupId': 'OG002'}]}]}, {'title': '3 months', 'categories': [{'measurements': [{'value': '14.0', 'spread': '3.0', 'groupId': 'OG000'}, {'value': '14.7', 'spread': '2.5', 'groupId': 'OG001'}, {'value': '13.6', 'spread': '2.4', 'groupId': 'OG002'}]}]}, {'title': '6 months', 'categories': [{'measurements': [{'value': '14.6', 'spread': '2.2', 'groupId': 'OG000'}, {'value': '15.0', 'spread': '2.5', 'groupId': 'OG001'}, {'value': '13.8', 'spread': '2.9', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': '6 months', 'description': 'Time to exhaustion during incremental cycling test performed at 0, 3 and 6 months', 'unitOfMeasure': 'minutes', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'SECONDARY', 'title': 'Capillary Lactate', 'denoms': [{'units': 'Participants', 'counts': [{'value': '10', 'groupId': 'OG000'}, {'value': '15', 'groupId': 'OG001'}, {'value': '14', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Control', 'description': 'continued their omnivorous diet throughout the entire study'}, {'id': 'OG001', 'title': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine\n\nVegetarian diet\n\nPlacebo: pills'}, {'id': 'OG002', 'title': 'Veg+Suppl', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day\n\nVegetarian diet\n\ncreatine and beta-alanine'}], 'classes': [{'title': 'Baseline - start', 'categories': [{'measurements': [{'value': '1.9', 'spread': '0.5', 'groupId': 'OG000'}, {'value': '2.0', 'spread': '0.7', 'groupId': 'OG001'}, {'value': '1.8', 'spread': '0.8', 'groupId': 'OG002'}]}]}, {'title': 'Baseline - end', 'categories': [{'measurements': [{'value': '10.7', 'spread': '1.6', 'groupId': 'OG000'}, {'value': '12.4', 'spread': '4.2', 'groupId': 'OG001'}, {'value': '10.7', 'spread': '2.7', 'groupId': 'OG002'}]}]}, {'title': '3 months - start', 'categories': [{'measurements': [{'value': '2.4', 'spread': '1.0', 'groupId': 'OG000'}, {'value': '2.0', 'spread': '0.9', 'groupId': 'OG001'}, {'value': '2.2', 'spread': '0.9', 'groupId': 'OG002'}]}]}, {'title': '3 months - end', 'categories': [{'measurements': [{'value': '11.4', 'spread': '2.6', 'groupId': 'OG000'}, {'value': '14.1', 'spread': '2.1', 'groupId': 'OG001'}, {'value': '12.2', 'spread': '2.3', 'groupId': 'OG002'}]}]}, {'title': '6 months - start', 'categories': [{'measurements': [{'value': '2.0', 'spread': '0.5', 'groupId': 'OG000'}, {'value': '1.7', 'spread': '0.4', 'groupId': 'OG001'}, {'value': '2.2', 'spread': '1.1', 'groupId': 'OG002'}]}]}, {'title': '6 months - end', 'categories': [{'measurements': [{'value': '12.1', 'spread': '2.0', 'groupId': 'OG000'}, {'value': '12.7', 'spread': '1.1', 'groupId': 'OG001'}, {'value': '13.1', 'spread': '2.1', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': '6 months', 'description': 'capillary lactate at the start and at the end of the incremental cycling test performed at 0, 3 and 6 months', 'unitOfMeasure': 'mmol/L', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'SECONDARY', 'title': 'Capillary pH', 'denoms': [{'units': 'Participants', 'counts': [{'value': '10', 'groupId': 'OG000'}, {'value': '15', 'groupId': 'OG001'}, {'value': '14', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Control', 'description': 'continued their omnivorous diet throughout the entire study'}, {'id': 'OG001', 'title': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine\n\nVegetarian diet\n\nPlacebo: pills'}, {'id': 'OG002', 'title': 'Veg+Suppl', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day\n\nVegetarian diet\n\ncreatine and beta-alanine'}], 'classes': [{'title': 'Baseline - start', 'categories': [{'measurements': [{'value': '7.4', 'spread': '0.02', 'groupId': 'OG000'}, {'value': '7.41', 'spread': '0.02', 'groupId': 'OG001'}, {'value': '7.42', 'spread': '0.02', 'groupId': 'OG002'}]}]}, {'title': 'Baseline - end', 'categories': [{'measurements': [{'value': '7.28', 'spread': '0.03', 'groupId': 'OG000'}, {'value': '7.24', 'spread': '0.07', 'groupId': 'OG001'}, {'value': '7.28', 'spread': '0.06', 'groupId': 'OG002'}]}]}, {'title': '3 months - start', 'categories': [{'measurements': [{'value': '7.4', 'spread': '0.03', 'groupId': 'OG000'}, {'value': '7.42', 'spread': '0.03', 'groupId': 'OG001'}, {'value': '7.41', 'spread': '0.01', 'groupId': 'OG002'}]}]}, {'title': '3 months - end', 'categories': [{'measurements': [{'value': '7.27', 'spread': '0.04', 'groupId': 'OG000'}, {'value': '7.23', 'spread': '0.04', 'groupId': 'OG001'}, {'value': '7.26', 'spread': '0.04', 'groupId': 'OG002'}]}]}, {'title': '6 months - start', 'categories': [{'measurements': [{'value': '7.42', 'spread': '0.04', 'groupId': 'OG000'}, {'value': '7.43', 'spread': '0.02', 'groupId': 'OG001'}, {'value': '7.43', 'spread': '0.01', 'groupId': 'OG002'}]}]}, {'title': '6 months - end', 'categories': [{'measurements': [{'value': '7.29', 'spread': '0.05', 'groupId': 'OG000'}, {'value': '7.27', 'spread': '0.03', 'groupId': 'OG001'}, {'value': '7.28', 'spread': '0.04', 'groupId': 'OG002'}]}]}], 'paramType': 'MEAN', 'timeFrame': '6 months', 'description': 'capillary pH at the start and at the end of the incremental cycling test performed at 0, 3 and 6 months', 'unitOfMeasure': 'pH', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}]}, 'participantFlowModule': {'groups': [{'id': 'FG000', 'title': 'Control', 'description': 'continued their omnivorous diet throughout the entire study'}, {'id': 'FG001', 'title': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine\n\nVegetarian diet\n\nPlacebo: pills'}, {'id': 'FG002', 'title': 'Veg+Suppl', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day\n\nVegetarian diet\n\ncreatine and beta-alanine'}], 'periods': [{'title': '0-3 Months', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '10'}, {'groupId': 'FG001', 'numSubjects': '15'}, {'groupId': 'FG002', 'numSubjects': '15'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '10'}, {'groupId': 'FG001', 'numSubjects': '15'}, {'groupId': 'FG002', 'numSubjects': '14'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '1'}]}]}, {'title': '3-6 Months', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '10'}, {'groupId': 'FG001', 'numSubjects': '15'}, {'groupId': 'FG002', 'numSubjects': '14'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '10'}, {'groupId': 'FG001', 'numSubjects': '15'}, {'groupId': 'FG002', 'numSubjects': '14'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}]}]}]}, 'baselineCharacteristicsModule': {'denoms': [{'units': 'Participants', 'counts': [{'value': '10', 'groupId': 'BG000'}, {'value': '15', 'groupId': 'BG001'}, {'value': '15', 'groupId': 'BG002'}, {'value': '40', 'groupId': 'BG003'}]}], 'groups': [{'id': 'BG000', 'title': 'Control', 'description': 'continued their omnivorous diet throughout the entire study'}, {'id': 'BG001', 'title': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine\n\nVegetarian diet\n\nPlacebo: pills'}, {'id': 'BG002', 'title': 'Veg+Suppl', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day\n\nVegetarian diet\n\ncreatine and beta-alanine'}, {'id': 'BG003', 'title': 'Total', 'description': 'Total of all reporting groups'}], 'measures': [{'title': 'Age, Continuous', 'classes': [{'categories': [{'measurements': [{'value': '25.9', 'spread': '9', 'groupId': 'BG000'}, {'value': '26.1', 'spread': '7.5', 'groupId': 'BG001'}, {'value': '25.5', 'spread': '6.6', 'groupId': 'BG002'}, {'value': '25.6', 'spread': '7.3', 'groupId': 'BG003'}]}]}], 'paramType': 'MEAN', 'unitOfMeasure': 'years', 'dispersionType': 'STANDARD_DEVIATION'}, {'title': 'Sex: Female, Male', 'classes': [{'categories': [{'title': 'Female', 'measurements': [{'value': '10', 'groupId': 'BG000'}, {'value': '15', 'groupId': 'BG001'}, {'value': '15', 'groupId': 'BG002'}, {'value': '40', 'groupId': 'BG003'}]}, {'title': 'Male', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Race (NIH/OMB)', 'classes': [{'categories': [{'title': 'American Indian or Alaska Native', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}]}, {'title': 'Asian', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}]}, {'title': 'Native Hawaiian or Other Pacific Islander', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}]}, {'title': 'Black or African American', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}]}, {'title': 'White', 'measurements': [{'value': '10', 'groupId': 'BG000'}, {'value': '15', 'groupId': 'BG001'}, {'value': '15', 'groupId': 'BG002'}, {'value': '40', 'groupId': 'BG003'}]}, {'title': 'More than one race', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}]}, {'title': 'Unknown or Not Reported', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Region of Enrollment', 'classes': [{'title': 'Belgium', 'categories': [{'measurements': [{'value': '10', 'groupId': 'BG000'}, {'value': '15', 'groupId': 'BG001'}, {'value': '15', 'groupId': 'BG002'}, {'value': '40', 'groupId': 'BG003'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'TRIPLE', 'whoMasked': ['PARTICIPANT', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR'], 'maskingDescription': 'A co-worker, not involved in the study design and analysis, will perform the randomisation and will prepare the containers with supplements. Only the control group will know that they are part of the control group (continuing omnivorous diet). For the vegetarian groups, subject will not know whether they are in the supplemented group or not because placebo supplements will be used'}, 'primaryPurpose': 'BASIC_SCIENCE', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'The study was scheduled over a period of 6 months. Of the 40 subjects, 10 women will continue their omnivorous diet throughout the entire study (controls) and the other 30 subjects will switch to a lacto-ovo-vegetarian diet for 6 months. The vegetarian group will be split in 2 groups, matched for age, weight, height and baseline carnosine concentrations in soleus and gastrocnemius medialis muscles. Fifteen of them will be supplemented with beta-alanine and creatine (Veg+Suppl) and the other 15 women will receive a placebo (Veg+Pla).'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 40}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2012-12', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2018-10', 'completionDateStruct': {'date': '2013-06', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2018-10-25', 'studyFirstSubmitDate': '2017-06-15', 'resultsFirstSubmitDate': '2017-07-31', 'studyFirstSubmitQcDate': '2017-06-20', 'lastUpdatePostDateStruct': {'date': '2019-02-28', 'type': 'ACTUAL'}, 'resultsFirstSubmitQcDate': '2018-10-25', 'studyFirstPostDateStruct': {'date': '2017-06-21', 'type': 'ACTUAL'}, 'resultsFirstPostDateStruct': {'date': '2019-02-28', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2013-06', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Fasted Plasma Beta-alanine Concentration', 'timeFrame': '6 months', 'description': 'Fasted venous plasma beta-alanine concentration (precursor for carnosine) at 0, 3 and 6 months of the intervention'}, {'measure': 'Gastrocnemius Carnosine Concentration', 'timeFrame': '6 months', 'description': 'Gastrocnemius carnosine concentration at 0, 3 and 6 months of the intervention'}, {'measure': 'Soleus Carnosine Concentration', 'timeFrame': '6 months', 'description': 'Soleus carnosine concentration at 0, 3 and 6 months of the intervention'}, {'measure': 'Plasma Creatine Concentration', 'timeFrame': '6 months', 'description': 'Plasma creatine concentration at 0, 3 and 6 months of the intervention'}, {'measure': 'Plasma Creatinine Concentration', 'timeFrame': '6 months', 'description': 'Plasma creatinine at 0, 3 and 6 months of the intervention'}, {'measure': 'Plasma Guanidinoacetate Concentration', 'timeFrame': '6 months', 'description': 'Plasma guanidinoacetate at 0, 3 and 6 months of the intervention'}, {'measure': 'Urinary Creatinine Concentration', 'timeFrame': '6 months', 'description': 'Urinary creatinine at 0, 3 and 6 months of the intervention'}, {'measure': 'Muscle Creatine Concentration', 'timeFrame': '3 months', 'description': 'Muscle total creatine concentration in vastus lateralis muscle at 0 and 3 months of the intervention'}, {'measure': 'Plasma Carnitine Concentration', 'timeFrame': '6 months', 'description': 'plasma free carnitine concentration at 0, 3 and 6 months of the intervention'}, {'measure': 'Plasma Acetylcarnitine Concentration', 'timeFrame': '6 months', 'description': 'plasma acetylcarnitine concentration at 0, 3 and 6 months of the intervention'}, {'measure': 'Plasma Total Carnitine Concentration', 'timeFrame': '6 months', 'description': 'plasma total carnitine concentration (free + acetyl) at 0, 3 and 6 months of the intervention'}, {'measure': 'Muscle Carnitine Concentration', 'timeFrame': '3 months', 'description': 'muscle free carnitine concentration in vastus lateralis muscle at 0 and 3 months of the intervention'}, {'measure': 'Muscle Acetylcarnitine Concentration', 'timeFrame': '3 months', 'description': 'muscle acetylcarnitine concentration in vastus lateralis muscle at 0 and 3 months of the intervention'}, {'measure': 'Muscle Total Carnitine Concentration', 'timeFrame': '3 months', 'description': 'muscle total carnitine concentration (free + acetylcarnitine) in vastus lateralis muscle at 0 and 3 months of the intervention'}], 'secondaryOutcomes': [{'measure': 'Vitamin D Status', 'timeFrame': '6 months', 'description': 'Serum 25-Hydroxyvitamin D concentration at 0, 3 and 6 months of the intervention'}, {'measure': 'Urinary Biomarker for Meat Intake: Pi-methyl-histidine', 'timeFrame': '6 months', 'description': 'urinary pi-methyl-histidine concentration at 0, 3 and 6 months of the intervention'}, {'measure': 'Urinary Biomarker for Meat Intake: Tau-methyl-histidine', 'timeFrame': '6 months', 'description': 'urinary tau-methyl-histidine concentration at 0, 3 and 6 months of the intervention'}, {'measure': 'Urinary Biomarker for Meat Intake: Anserine', 'timeFrame': '6 months', 'description': 'urinary anserine concentration at 0, 3 and 6 months of the intervention'}, {'measure': 'VO2max', 'timeFrame': '6 months', 'description': 'VO2max during incremental cycling test performed at 0, 3 and 6 months'}, {'measure': 'Time to Exhaustion', 'timeFrame': '6 months', 'description': 'Time to exhaustion during incremental cycling test performed at 0, 3 and 6 months'}, {'measure': 'Capillary Lactate', 'timeFrame': '6 months', 'description': 'capillary lactate at the start and at the end of the incremental cycling test performed at 0, 3 and 6 months'}, {'measure': 'Capillary pH', 'timeFrame': '6 months', 'description': 'capillary pH at the start and at the end of the incremental cycling test performed at 0, 3 and 6 months'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['vegetarianism', 'creatine', 'carnosine', 'carnitine'], 'conditions': ['Dietary Modification']}, 'referencesModule': {'references': [{'pmid': '31593541', 'type': 'DERIVED', 'citation': 'Van Dyck D, Herman K, Poppe L, Crombez G, De Bourdeaudhuij I, Gheysen F. Results of MyPlan 2.0 on Physical Activity in Older Belgian Adults: Randomized Controlled Trial. J Med Internet Res. 2019 Oct 7;21(10):e13219. doi: 10.2196/13219.'}, {'pmid': '29569535', 'type': 'DERIVED', 'citation': 'Blancquaert L, Baguet A, Bex T, Volkaert A, Everaert I, Delanghe J, Petrovic M, Vervaet C, De Henauw S, Constantin-Teodosiu D, Greenhaff P, Derave W. Changing to a vegetarian diet reduces the body creatine pool in omnivorous women, but appears not to affect carnitine and carnosine homeostasis: a randomised trial. Br J Nutr. 2018 Apr;119(7):759-770. doi: 10.1017/S000711451800017X.'}]}, 'descriptionModule': {'briefSummary': 'Balanced vegetarian diets are popular and contain health-promoting characteristics. A balanced lacto-ovo-vegetarian diet differs in nutrient intake from an omnivorous diet, e.g. by increased intake of fibre, magnesium and antioxidants, but lower intake of omega-3 fatty acids and vitamin B12. However, the impact of reduced to near absent intake of carnitine, carnosine and creatine in a vegetarian diet is less well established and could be relevant in relation to muscle function, exercise capacity and sports performance. Few longitudinal intervention studies investigating the effect of a vegetarian diet on the availability of these compounds currently exist.\n\nThis study aimed therefore to investigate the effect of of transiently switching omnivores onto a vegetarian diet for 6 months on muscle and plasma creatine, carnitine and carnosine homeostasis.\n\nWe hypothesized that homeostasis of creatine and carnosine would be disrupted when their dietary intake was missing. For carnitine, however, we hypothesized that homeostasis can be maintained given its slow turnover rate and its presence in some non-meat nutrients. A second aim was to investigate whether supplementation of creatine and beta-alanine (the rate-limiting precursor of carnosine synthesis), concurrently with a lacto-ovo-vegetarian diet, was able to correct for potentially emerging deficiencies.', 'detailedDescription': "Forty healthy female omnivores will be included in this 6-month intervention study. Exclusion criteria are smoking, chronic use of medication, athletes participating in competitions, vegetarianism or eating meat or fish less than 5 times a week. The study is scheduled over a period of 6 months and measurements will be performed 1 week prior to the intervention (0M), after 3 months (3M) and within the last week (6M). Ten women will continue their omnivorous diet throughout the entire study (controls) and the other 30 subjects will switch to a lacto-ovo-vegetarian diet for 6 months. The vegetarian group will be split in 2 groups, matched for age, weight, height and baseline carnosine concentrations in soleus and gastrocnemius medialis muscles. Fifteen of them will be supplemented with beta-alanine and creatine (Veg+Suppl) and the other 15 women will receive a placebo (Veg+Pla). A co-worker, not involved in the study design and analysis, will perform the randomisation and will prepare the containers with supplements. With regard to supplementation, the study is double-blind placebo-controlled. The lacto-ovo-vegetarian diet consists of vegetables, fruits, seeds, grains, meat substitutes, eggs and dairy products and the exclusion of meat, poultry and fish. Subjects will complete a 3 day food diary at the start and after 3 months and will receive nutritional advice by a dietician during the study to prevent deficiencies in macronutrients and micronutrients. Furthermore, vegetarian recipes will be provided by email to support the subjects in their vegetarian diet.\n\nThe supplementation protocol includes simultaneously daily oral administration of creatine monohydrate (Creapure®, AlzChem AG, Germany) and slow-release beta-alanine (Carnosyn®, Natural Alternatives International, San Marcos, USA) or a placebo (maltodextrin, Natural spices, France). The supplements are considered as safe and efficacious. The Veg+Suppl group ingests 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day during the intervention period. The Veg+Pla group will be supplemented with an identical number of capsules and tablets of maltodextrin. All subjects are asked not to take any other supplements than those provided by the current study. Compliance will be checked by asking the subjects to return the containers and counting the pills that are left. The control group, who will remain on an omnivorous diet, will not receive any supplements.\n\nBefore (0M), after 3 (3M) and 6 months (6M), subjects will perform an incremental cycling test, a fasted venous blood sample and 24hr urine will be collected, a muscle biopsy of the vastus lateralis muscle will be taken and muscle carnosine content will be determined by 1H-MRS.\n\nA two-way analysis of variance (ANOVA) will be used to evaluate plasma and urinary metabolite concentrations, muscle carnosine, muscle biopsy metabolite concentrations, time to exhaustion (TTE) and VO2max with 'group' (Veg+Suppl; Veg+Pla; control) as between-subject factor and 'time' (0M; 3M; 6M) as within-subject factor (SPSS statistical software, SPSS Inc, Chicago, USA). For the analysis of capillary lactate and pH, measurements before and after the incremental cycling test were included as another within factor (start; end). In case of significance, analyses were repeated for each group separately and pairwise comparisons were used to compare the different time points. Values will be presented as mean ± SD and statistical significance threshold will be set at p ≤0.05."}, 'eligibilityModule': {'sex': 'FEMALE', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': True, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* women\n\nExclusion Criteria:\n\n* smoking, chronic use of medication or taking supplements, athletes participating in competitions, vegetarianism or eating meat or fish less than 5 times a week'}, 'identificationModule': {'nctId': 'NCT03194334', 'briefTitle': 'Creatine, Carnitine and Carnosine in Vegetarians', 'organization': {'class': 'OTHER', 'fullName': 'University Ghent'}, 'officialTitle': 'Effect of a 6-month Vegetarian Diet in Omnivorous Women on Body Creatine, Carnitine and Carnosine Stores', 'orgStudyIdInfo': {'id': 'EC/2012/666'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'NO_INTERVENTION', 'label': 'Control', 'description': 'continued their omnivorous diet throughout the entire study'}, {'type': 'EXPERIMENTAL', 'label': 'Veg+Pla', 'description': 'vegetarian + placebo: switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with placebo pills instead of beta-alanine and creatine', 'interventionNames': ['Behavioral: Vegetarian diet', 'Dietary Supplement: Placebo']}, {'type': 'EXPERIMENTAL', 'label': 'Veg+ creatine and beta-alanine', 'description': 'switch to a lacto-ovo-vegetarian diet for 6 months and are supplemented with 1 g of creatine monohydrate (2 capsules of 500 mg) and 0.8 g of beta-alanine (1 Carnosyn® tablet) each day', 'interventionNames': ['Behavioral: Vegetarian diet', 'Dietary Supplement: creatine', 'Dietary Supplement: Beta-alanine']}], 'interventions': [{'name': 'Vegetarian diet', 'type': 'BEHAVIORAL', 'otherNames': ['lacto-ovo-vegetarian diet'], 'armGroupLabels': ['Veg+ creatine and beta-alanine', 'Veg+Pla']}, {'name': 'creatine', 'type': 'DIETARY_SUPPLEMENT', 'description': '1g creatine/day', 'armGroupLabels': ['Veg+ creatine and beta-alanine']}, {'name': 'Placebo', 'type': 'DIETARY_SUPPLEMENT', 'description': 'pills', 'armGroupLabels': ['Veg+Pla']}, {'name': 'Beta-alanine', 'type': 'DIETARY_SUPPLEMENT', 'description': '0.8g beta-alanine per day', 'armGroupLabels': ['Veg+ creatine and beta-alanine']}]}, 'contactsLocationsModule': {'overallOfficials': [{'name': 'Wim Derave, Professor', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'University Ghent'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO', 'description': 'individual data will not be made available to other researchers'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'University Ghent', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR'}}}}